Liver Diseases: all 2,094 studies
Page 14 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Antidiabetic Drugs for Steatotic Liver DiseaseCompletedNCT03646292Phase 4
- A Validation Cohort for ACLF Diagnosis and PrognosisCompletedNCT03641872
- Effect of Preoperative Beta Blocker Use Postoperative Renal Function in the Patients Undergoing Liver TransplantationStatus unknownNCT03633812
- Effect of Liver MSCs in Blood of Patients With Liver Disease.CompletedNCT03632148
- Plant Sterols and Plant Stanols and Liver InflammationStatus unknownNCT03627819Not applicable
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of GlasdegibCompletedNCT03627754Phase 1
- Hydrogen-rich Water for Non-alchoholic Fatty Liver DiseaseCompletedNCT03625362Not applicable
- Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver ResectionStatus unknownNCT03620916Not applicable
- Effect of Probiotic and Smectite Gel on NAFLDCompletedNCT03614039Not applicable
- Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)Status unknownNCT03613480Not applicable
- Splenectomy During Whole Liver TransplantationCompletedNCT03609411
- Early Detection of Advanced Fatty Liver DiseaseCompletedNCT03608748
- MRE-IA in Liver Disease and Neurovascular ImagingCompletedNCT03601845Not applicable
- The Effect and Safety of the Four Points Transversus Abdominis Plane BlockCompletedNCT03598192Not applicable
- A Study in Healthy VolunteersCompletedNCT03596697Phase 1
- To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected PatientsCompletedNCT03593447Phase 2
- Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver DiseaseStatus unknownNCT03591783
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCompletedNCT03590626Not applicable
- Haemostatic Imbalance in Patients With Chronic Liver DiseaseStatus unknownNCT03589430
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of ErdafitinibTerminatedNCT03587363Phase 1
- Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT03587298
- Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver TransplantationCompletedNCT03584646Not applicable
- Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.CompletedNCT03583437Not applicable
- Association Between Nonalcoholic Fatty Liver Disease and Acute PancreatitisCompletedNCT03566173
- Portal Blood Flushes in the Peri-Reperfusion Stage of Liver TransplantationCompletedNCT03563404
- Immunological Measurement of Aspartate/Alanine AminotransferaseCompletedNCT03562585
- Omegaven Protocol:Intermediate Size Patient PopulationApproved for marketingNCT03561194
- Study of Danicopan in Participants With Hepatic ImpairmentCompletedNCT03555539Phase 1
- Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a ProcedureTerminatedNCT03554759
- Structured Exercise Prescription Program in Obese ChildrenStatus unknownNCT03552367Not applicable
- Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model StudyStatus unknownNCT03534908
- Hepatic Metabolic Changes in Response to Glucagon InfusionCompletedNCT03526445Not applicable
- Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver TransplantationActive, not recruitingNCT03522688Phase 4
- Rucaparib Hepatic Impairment Study in Patients With a Solid TumorCompletedNCT03521037Phase 1
- Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver DysfunctionActive, not recruitingNCT03519074Phase 2
- Reducing Disparities in the Quality of Advance Care Planning for Older AdultsCompletedNCT03516994Not applicable
- An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver FunctionCompletedNCT03515980Phase 1
- YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03512184Not applicable
- Effects of Probiotic on Inflammation and Microbiota in Patients With NASHTerminatedNCT03511365Phase 1/2
- Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver InsufficiencyStatus unknownNCT03509194
- Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic CirrhosisTerminatedNCT03508388
- A Study of LY3314814 in Participants With Liver ImpairmentWithdrawnNCT03499041Phase 1
- Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD TrialCompletedNCT03493204Not applicable
- Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases SeverityStatus unknownNCT03492879Not applicable
- Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis StageStatus unknownNCT03487159Not applicable
- Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT03487068Not applicable
- MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)CompletedNCT03483272
- Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or PlaceboTerminatedNCT03479125
- AlcoChange: An Open Label Pilot Study of Smartphone Monitoring for Alcoholic Liver DiseaseStatus unknownNCT03474328Not applicable
- Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver TransplantationWithdrawnNCT03468140Early Phase 1
- Probiotics in NASH Patients - PROBILIVER TRIALStatus unknownNCT03467282Not applicable
- Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLDCompletedNCT03461562Not applicable
- Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.CompletedNCT03459521Not applicable
- Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver DiseaseCompletedNCT03456518
- A Study of Experimental Medication BMS-986036 Given to Healthy ParticipantsCompletedNCT03445208Phase 1
- Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.CompletedNCT03444233Phase 4
- Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive AssessmentCompletedNCT03443934
- Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical OutcomesCompletedNCT03442361
- Superior Silybin Bioavailability in Healthy VolunteersCompletedNCT03440164
- Effects of Carnitine Supplementation on Liver and MuscleCompletedNCT03439917Not applicable
- MRI to Assess the Effect of Non-selective Beta-blocker in Patients With CirrhosisCompletedNCT03438916
- Fluorescence Spectroscopy for Gut Permeability AssessmentStatus unknownNCT03434639
- Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver DiseaseCompletedNCT03434613Phase 4
- Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).Status unknownNCT03426111Not applicable
- Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic ImpairmentCompletedNCT03423446Phase 1
- Applicability of 3D Printing and 3D Digital Image Reconstruction in the Planning of Complex Liver Surgery (LIV3DPRINT).Status unknownNCT03416387Not applicable
- Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyCompletedNCT03405909
- Text Messaging to Reduce Alcohol Relapse in Liver Transplant PatientsCompletedNCT03402256Not applicable
- Liver Transplantation: Skeletal EffectsWithdrawnNCT03399227
- The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa AntagonistCompletedNCT03397888Phase 1
- Liver RegenerationTerminatedNCT03396705
- SWE Liver Stiffness as a Predictor of Progression of Chronic Liver DiseasesCompletedNCT03389152
- Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease PopulationStatus unknownNCT03388320Not applicable
- Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver FibrosisStatus unknownNCT03386890
- The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03377153Not applicable
- The Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03377140Not applicable
- Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its MetabolitesCompletedNCT03376841Phase 1
- Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLDStatus unknownNCT03375580Not applicable
- Obstructive Sleep Apnea and Non-alcoholic Fatty Liver DiseaseStatus unknownNCT03373643Not applicable
- Study of Hemodynamic Conditions Measured During HepatectomyCompletedNCT03371537
- High-fat Overfeeding, Hepatokines and Appetite RegulationCompletedNCT03369145Not applicable
- Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy SubjectsCompletedNCT03369002Phase 1
- Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese PopulationCompletedNCT03366987
- RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver DiseaseTerminatedNCT03365531Not applicable
- A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)Status unknownNCT03363451
- A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)Status unknownNCT03362632
- Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia TelangiectasiaStatus unknownNCT03357978Not applicable
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCompletedNCT03357380Phase 1
- Lifestyle Intervention in Fatty Liver (NAFLD)Status unknownNCT03354247Not applicable
- 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health OutcomesCompletedNCT03353701Not applicable
- A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03350165Phase 2
- Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic FibrosisCompletedNCT03312140Not applicable
- Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle MedicineCompletedNCT03300661Not applicable
- Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)Status unknownNCT03295812
- A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.CompletedNCT03290443Phase 1
- A Study of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic FunctionCompletedNCT03282513Phase 1
- Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT03281083Phase 2
- Thermal Imaging in Liver Disease.CompletedNCT03279419
- Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C VirusCompletedNCT03276039
- Whole Body Electromyostimulation and Nutritional Therapy for Patients With Chronic Liver DiseaseStatus unknownNCT03274388Not applicable